Format

Send to

Choose Destination
See comment in PubMed Commons below
Nature. 1992 Apr 30;356(6372):768-74.

A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes.

Author information

1
Department of Biochemistry, Merck Research Laboratories, Rahway, New Jersey 07065.

Abstract

Interleukin-1 beta (IL-1 beta)-converting enzyme cleaves the IL-1 beta precursor to mature IL-1 beta, an important mediator of inflammation. The identification of the enzyme as a unique cysteine protease and the design of potent peptide aldehyde inhibitors are described. Purification and cloning of the complementary DNA indicates that IL-1 beta-converting enzyme is composed of two nonidentical subunits that are derived from a single proenzyme, possibly by autoproteolysis. Selective inhibition of the enzyme in human blood monocytes blocks production of mature IL-1 beta, indicating that it is a potential therapeutic target.

PMID:
1574116
DOI:
10.1038/356768a0
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group
    Loading ...
    Support Center